How do world and European standard populations impact burden of disease studies? A case study of disability-adjusted life years (DALYs) in Scotland

Archives of Public Health - Tập 78 Số 1 - 2020
Grant M. A. Wyper1, Ian Grant2, Eilidh Fletcher2, Gerry McCartney1, Colin Fischbacher2, Diane Stockton1
1Public Health Science Directorate, NHS Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow, G2 6QE, Scotland
2Information Services Division, NHS National Services Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh, EH12 9EB, Scotland

Tóm tắt

Abstract Background Disability-Adjusted Life Years (DALYs) are an established method for quantifying population health needs and guiding prioritisation decisions. Global Burden of Disease (GBD) estimates aim to ensure comparability between countries and over time by using age-standardised rates (ASR) to account for differences in the age structure of different populations. Different standard populations are used for this purpose but it is not widely appreciated that the choice of standard may affect not only the resulting rates but also the rankings of causes of DALYs. We aimed to evaluate the impact of the choice of standard, using the example of Scotland. Methods DALY estimates were derived from the 2016 Scottish Burden of Disease (SBoD) study for an abridged list of 68 causes of disease/injury, representing a three-year annual average across 2014–16. Crude DALY rates were calculated using Scottish national population estimates. DALY ASRs standardised using the GBD World Standard Population (GBD WSP) were compared to those using the 2013 European Standard Population (ESP2013). Differences in ASR and in rank order within the cause list were summarised for all-cause and for each individual cause. Results The ranking of causes by DALYs were similar using crude rates or ASR (ESP2013). All-cause DALY rates using ASR (GBD WSP) were around 26% lower. Overall 58 out of 68 causes had a lower ASR using GBD WSP compared with ESP2013, with the largest falls occurring for leading causes of mortality observed in older ages. Gains in ASR were much smaller in absolute scale and largely affected causes that operated early in life. These differences were associated with a substantial change to the ranking of causes when GBD WSP was used compared with ESP2013. Conclusion Disease rankings based on DALY ASRs are strongly influenced by the choice of standard population. While GBD WSP offers international comparability, within-country analyses based on DALY ASRs should reflect local age structures. For European countries, including Scotland, ESP2013 may better guide local priority setting by avoiding large disparities occurring between crude and age-standardised results sets, which could potentially confuse non-technical audiences.

Từ khóa


Tài liệu tham khảo

Murray CJL, Lopez AD. The Global Burden of Disease: A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard University Press on behalf of the World Health Organization and the World Bank; 1996.

Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CLJ. Global Burden of Disease and Risk Factors. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2006. Available from: https://www.ncbi.nlm.nih.gov/books/NBK11812/ Co-published by Oxford University Press, New York.

Institute for Health Metrics and Evaluation [Internet]. The Global Burden of Disease (GBD). http://www.healthdata.org/gbd. Accessed 27 Sept 2019.

Institute for Health Metrics and Evaluation. The global burden of disease: generating evidence, guiding policy. Seattle: IHME; 2013.

Rommel A, von der Lippe E, Plaß D, Wengler A, Anton A, Schmidt C, et al. BURDEN 2020—Burden of disease in Germany at the national and regional level. Bundesgesundheitsblatt—Gesundheitsforsch—Gesundheitsschutz. 2018;61(9):1159–66.

Scottish Public Health Observatory. Scottish Burden of Disease study. https://www.scotpho.org.uk/comparative-health/burden-of-disease/overview. Accessed 27 Sept 2019.

Devleesschauwer B. Country Report: the Belgian National Burden of Disease Study 2020. Eur J Public Health. 2018;28(suppl_4):283–283.

O’Donovan MR, Gapp C, Stein C. Burden of disease studies in the WHO European region—a mapping exercise. Eur J of Public Health. 2018;28(4):773–8.

Mesalles-Naranjo O, Grant I, Wyper GMA, Stockton D, Dobbie R, McFadden M, et al. Trends and inequalities in the burden of mortality in Scotland 2000–2015. PLoS One. 2018;13(8):e0196906. https://doi.org/10.1371/journal.pone.0196906.

GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–88.

Eurostat. Revision of the European Standard Population Report of Eurostat's task force. Luxembourg: Publications Office of the European Union; 2013.

GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858.

National Records of Scotland. Population. https://www.nrscotland.gov.uk/statistics-and-data/statistics/statistics-by-theme/population. Accessed 27 Sept 2019.

National Cancer Institute. [Internet] Surveillance, Epidemiology, and End Results (SEER) Program. https://seer.cancer.gov/stdpopulations/. Accessed 27 Sept 2019.

Australian Bureau of Statistics, Australian Government. Population. https://www.abs.gov.au/Population. Accessed 27 Sept 2019.

Danckert B, Ferlay J, Engholm G, Hansen HL, Johannesen TB, Khan S, et al. NORDCAN: Cancer incidence, mortality, prevalence and survival in the Nordic countries, version 8.2 (26.03.2019). Association of the Nordic Cancer Registries. Danish Cancer Society. Available from http://www.ancr.nu.

Wyper GMA, Grant I, Fletcher E, McCartney G, Stockton DL. The impact of worldwide, national and sub-national severity distributions in Burden of Disease studies: A case study of cancers in Scotland. PLoS One. 2019;14(8).

Institute for Health Metrics and Evaluation. County profiles. Seattle: University of Washington, 2018. http://www.healthdata.org/results/country-profiles. Accessed 27 Sept 2019.

Institute for Health Metrics and Evaluation. GBD Results Tool. Seattle: University of Washington, 2018. http://ghdx.healthdata.org/gbd-results-tool. Accessed 27 Sept 2019.

Institute for Health Metrics and Evaluation. Data Visualizations. Seattle: University of Washington, 2018. http://www.healthdata.org/results/data-visualizations. Accessed 27 Sept 2019.

Stein C, Newton J. Sharing the burden: a new European burden of disease network is formed. Eur J Pub Health. 2017;27(2):191–2.

World Health Organisation. European Burden of Disease Network (EBoDN) http://www.euro.who.int/en/data-and-evidence/european-health-information-initiative-ehii/european-burden-of-disease-network-ebodn. Accessed 27 Sept 2019.

Thông tin
Thông tin xuất bản

Archives of Public Health

Tập 78 Số 1

Thông tin tác giả